ZBH

ZBH

USD

Zimmer Biomet Holdings Inc. Common Stock

$103.180+3.170 (3.170%)

Цена в режиме реального времени

Healthcare
Медицинские приборы
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$100.010

Максимум

$103.690

Минимум

$99.455

Объем

9.20M

Фундаментальные показатели компании

Рыночная капитализация

20.4B

Отрасль

Медицинские приборы

Страна

United States

Статистические данные торговли

Средний объем

1.41M

Биржа

NYQ

Валюта

USD

52-недельный диапазон

Минимум $89.22Текущая $103.180Максимум $114.72

Связанные новости

PR Newswire

Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the U.S. Food and Drug Administration (FDA) has ...

Просмотреть больше
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
Analyst Upgrades

Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Maintains $101 Price Target

Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings with a Hold and maintains $101 price target.

Просмотреть больше
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Maintains $101 Price Target
PR Newswire

Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting bold innovations across ...

Просмотреть больше
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting
Analyst Upgrades

BTIG Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $122

BTIG analyst Ryan Zimmerman maintains Zimmer Biomet Holdings with a Buy and raises the price target from $118 to $122.

Просмотреть больше
BTIG Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $122
PR Newswire

Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, a wholly owned subsidiary, today announced the...

Просмотреть больше
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases
Analyst Upgrades

Evercore ISI Group Maintains In-Line on Zimmer Biomet Holdings, Lowers Price Target to $104

Evercore ISI Group analyst Vijay Kumar maintains Zimmer Biomet Holdings with a In-Line and lowers the price target from $106 to $104.

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.